Evaluating Patient Experiences in Skin Care Clinical Studies

Sponsor
Power Life Sciences Inc. (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05738018
Collaborator
(none)
500
24

Study Details

Study Description

Brief Summary

Enrollment in clinical trials usually favors a particular demographic group. But there is limited research available to explain what study attributes affect the completion of these specific demographic groups.

This trial will evaluate the safety and efficacy of new skin care products and treatments. The focus will be on tracking the rates of completion and withdrawal among these individuals.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future skin care studies.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Case-Crossover
    Time Perspective:
    Prospective
    Official Title:
    An Observational Study Analyzing Patient Experiences in Skin Care Clinical Trials
    Anticipated Study Start Date :
    Mar 10, 2023
    Anticipated Primary Completion Date :
    Mar 10, 2024
    Anticipated Study Completion Date :
    Mar 10, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Rate of patients who decide to enroll in a skin care clinical study. [3 months]

    2. Number of skin care study participants who remain in clinical trial until completion. [12 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient is at least 18 years of age

    • Patient is able and willing to comply with the treatment/follow-up schedule and requirements

    • Patient must provide written informed consent

    Exclusion Criteria:
    • Women who are pregnant, intend to become pregnant, or are lactating

    • Inability to perform regular electronic reporting

    • Participants who are vulnerable to any intervention

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Power Life Sciences Inc.

    Investigators

    • Study Director: Michael B Gill, Power Life Sciences Inc.

    Study Documents (Full-Text)

    More Information

    Publications

    Responsible Party:
    Power Life Sciences Inc.
    ClinicalTrials.gov Identifier:
    NCT05738018
    Other Study ID Numbers:
    • 80190623
    First Posted:
    Feb 21, 2023
    Last Update Posted:
    Feb 21, 2023
    Last Verified:
    Feb 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Power Life Sciences Inc.

    Study Results

    No Results Posted as of Feb 21, 2023